These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 19428203)

  • 1. An assessment of sensing technologies for the detection of clandestine methamphetamine drug laboratories.
    Man G; Stoeber B; Walus K
    Forensic Sci Int; 2009 Aug; 189(1-3):1-13. PubMed ID: 19428203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clandestine drug laboratory situation in the United States.
    Frank RS
    J Forensic Sci; 1983 Jan; 28(1):18-31. PubMed ID: 6680736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commerce in drugs and chemicals and the detection of clandestine laboratories.
    Haislip GR
    Bull Narc; 1984; 36(1):25-31. PubMed ID: 6564900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing over-the-counter ephedrine and pseudoephedrine products to prescription only: impacts on methamphetamine clandestine laboratory seizures.
    Cunningham JK; Callaghan RC; Tong D; Liu LM; Li HY; Lattyak WJ
    Drug Alcohol Depend; 2012 Nov; 126(1-2):55-64. PubMed ID: 22592141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anhydrous ammonia thefts and releases associated with illicit methamphetamine production--16 states, January 2000-June 2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Apr; 54(14):359-61. PubMed ID: 15829866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capillary electrophoretic analysis of phosphorus species in clandestine methamphetamine laboratory samples.
    Knops LA; Northrop DM; Person EC
    J Forensic Sci; 2006 Jan; 51(1):82-6. PubMed ID: 16423227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clandestine drug laboratories in Australia and the potential for harm.
    Caldicott DG; Pigou PE; Beattie R; Edwards JW
    Aust N Z J Public Health; 2005 Apr; 29(2):155-62. PubMed ID: 15915620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The environmental impact and adverse health effects of the clandestine manufacture of methamphetamine.
    Irvine GD; Chin L
    NIDA Res Monogr; 1991; 115():33-46. PubMed ID: 1758481
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization and validation of ion mobility spectrometry in methamphetamine clandestine laboratory remediation.
    Moran J; McCall H; Yeager B; Bell S
    Talanta; 2012 Oct; 100():196-206. PubMed ID: 23141328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recoveries of trace pseudoephedrine and methamphetamine residues from impermeable household surfaces: implications for sampling methods used during remediation of clandestine methamphetamine laboratories.
    Abdullah AF; Miskelly GM
    Talanta; 2010 Apr; 81(1-2):455-61. PubMed ID: 20188946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposures associated with clandestine methamphetamine drug laboratories in Australia.
    Wright J; Edwards J; Walker S
    Rev Environ Health; 2016 Sep; 31(3):329-52. PubMed ID: 27428841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbial degradation of illicit drugs, their precursors, and manufacturing by-products: implications for clandestine drug laboratory investigation and environmental assessment.
    Janusz A; Kirkbride KP; Scott TL; Naidu R; Perkins MV; Megharaj M
    Forensic Sci Int; 2003 Jun; 134(1):62-71. PubMed ID: 12842360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of children removed from a clandestine methamphetamine laboratory.
    Grant P
    J Emerg Nurs; 2007 Feb; 33(1):31-41. PubMed ID: 17258050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of methamphetamine in the presence of nicotine using in situ chemical derivatization and ion mobility spectrometry.
    Ochoa ML; Harrington PB
    Anal Chem; 2004 Feb; 76(4):985-91. PubMed ID: 14961729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vehicle-Mounted Portable Mass Spectrometry System for the Covert Detection via Spatial Analysis of Clandestine Methamphetamine Laboratories.
    Mach PM; McBride EM; Sasiene ZJ; Brigance KR; Kennard SK; Wright KC; Verbeck GF
    Anal Chem; 2015 Nov; 87(22):11501-8. PubMed ID: 26457561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remediation of Manufactured Methamphetamine in Clandestine Laboratories. A Literature Review.
    Owens CV; Mason MM; Marr D
    J Chem Health Saf; 2017; 24(5):23-37. PubMed ID: 30505357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical hazards related to clandestine drug laboratories.
    Hughart JL
    Arh Hig Rada Toksikol; 2000 Sep; 51(3):305-10. PubMed ID: 11148935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends of clandestine laboratories manufacturing methamphetamine in New Zealand between 2009-2021: Evolution, enforcement, legislative, and COVID-19 effects.
    Bogun B; McKinnel M; Russell M; Watson J; Mayo E; Marr B; Larsen A; Craig J
    J Forensic Sci; 2023 Jan; 68(1):66-74. PubMed ID: 36268978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse Health Effects Associated with Living in a Former Methamphetamine Drug Laboratory - Victoria, Australia, 2015.
    Wright J; Kenneally ME; Edwards JW; Walker GS
    MMWR Morb Mortal Wkly Rep; 2017 Jan; 65(52):1470-1473. PubMed ID: 28056000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residual methamphetamine in decontaminated clandestine drug laboratories.
    Patrick G; Daniell W; Treser C
    J Occup Environ Hyg; 2009 Mar; 6(3):151-6. PubMed ID: 19116862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.